Inventor · disambiguated record
Thomas W. Chalberg, Jr.
Also filed as: CHALBERG JR THOMAS W · CHALBERG THOMAS W
24 granted patents·23 pending applications·190 citations·filing 2006–2025
95Inventor score
Files withSIGHTGLASS VISION INC13ADVERUM BIOTECHNOLOGIES INC7IRENIX MEDICAL INC6AVALANCHE AUSTRALIA PTY LTD4WAVESHIFT LLC4
Top patents by PatentIndex Score
47 records- 0196US10884264B2Ophthalmic lenses with light scattering for treating myopiaSIGHTGLASS VISION INC·Filed 2018·Granted Jan 5, 2021·58 cites·23 claims
- 0295US11914228B2Ophthalmic lenses with light scattering for treating myopiaSIGHTGLASS VISION INC·Filed 2021·Granted Feb 27, 2024·5 cites·20 claims
- 0395US11021519B2Compositions and methods for intravitreal delivery of polynucleotides to retinal conesADVERUM BIOTECHNOLOGIES INC·Filed 2016·Granted Jun 1, 2021·16 cites·24 claims
- 0494US7923251B2Method and apparatus for avalanche-mediated transfer of agents into cellsUNIV LELAND STANFORD JUNIOR·Filed 2006·Granted Apr 12, 2011·24 cites·20 claims
- 0591US8283171B2Method and apparatus for avalanche-mediated transfer of agents into cellsVANKOV ALEXANDER·Filed 2011·Granted Oct 9, 2012·19 cites·17 claims
- 0690US10004788B2Treatment of ocular neovascularization using anti-VEGF proteinsAVALANCHE AUSTRALIA PTY LTD·Filed 2017·Granted Jun 26, 2018·16 cites·27 claims
- 0788US12111518B2Ophthalmic lenses with dynamic optical properties for reducing development of myopiaSIGHTGLASS VISION INC·Filed 2020·Granted Oct 8, 2024·2 cites·24 claims
- 0888US11892714B2Using binocular rivalry for expanding color perceptionWAVESHIFT LLC·Filed 2022·Granted Feb 6, 2024·1 cites·18 claims
- 0987US11221501B2Using binocular rivalry for expanding color perceptionWAVESHIFT LLC·Filed 2018·Granted Jan 11, 2022·4 cites·17 claims
- 1087US9943573B2Treatment of ocular neovascularization using anti-VEGF proteinsAVALANCHE AUSTRALIA PTY LTD·Filed 2014·Granted Apr 17, 2018·15 cites·17 claims
- 1186US11248214B2Compositions and methods for enhanced gene expression in cone cellsADVERUM BIOTECHNOLOGIES INC·Filed 2018·Granted Feb 15, 2022·2 cites·28 claims
- 1286US10000741B2Compositions and methods for enhanced gene expression in cone cellsAVALANCHE BIOTECHNOLOGIES INC·Filed 2015·Granted Jun 19, 2018·8 cites·26 claims
- 1386US8101169B2Ocular gene therapy using avalanche-mediated transfectionCHALBERG JR THOMAS W·Filed 2006·Granted Jan 24, 2012·12 cites·20 claims
- 1485US10584328B2Mutant viral capsid libraries and related systems and methodsADVERUM BIOTECHNOLOGIES INC·Filed 2016·Granted Mar 10, 2020·3 cites·20 claims
- 1585US2025389974A1Ophthalmic lenses for reducing myopic progression and methods of making the sameSIGHTGLASS VISION INC·Filed 2025·Application pending·0 cites
- 1684US11205398B2Evaluating and reducing myopiagenic effects of electronic displaysWAVESHIFT LLC·Filed 2020·Granted Dec 21, 2021·2 cites·17 claims
- 1781US12468175B2Ophthalmic lenses with light scattering for treating myopiaSIGHTGLASS VISION INC·Filed 2024·Granted Nov 11, 2025·0 cites·18 claims
- 1881US11718052B2Contact lenses for reducing myopia and methods for making the sameSIGHTGLASS VISION INC·Filed 2018·Granted Aug 8, 2023·2 cites·16 claims
- 1980US2025352574A1Sodium Chlorite Compositions with Enhanced Anti-Viral and Anti-Microbial Efficacy and Reduced ToxicityIRENIX MEDICAL INC·Filed 2025·Application pending·0 cites
- 2077US12275959B2Compositions and methods for enhanced gene expression in cone cellsADVERUM BIOTECHNOLOGIES INC·Filed 2021·Granted Apr 15, 2025·0 cites·16 claims
- 2177US2025102833A1Ophthalmic lenses with dynamic optical properties for reducing development of myopiaSIGHTGLASS VISION INC·Filed 2024·Application pending·0 cites
- 2274US2023382064A1Contact lenses for reducing myopia and methods for making the sameSIGHTGLASS VISION INC·Filed 2023·Application pending·0 cites
- 2371US10621948B2Evaluating and reducing myopiagenic effects of electronic displaysWAVESHIFT LLC·Filed 2017·Granted Apr 14, 2020·1 cites·31 claims
- 2469US2022111015A1Treatment of ocular neovascularization using anti-vegf proteinsAVALANCHE AUSTRALIA PTY LTD·Filed 2021·Application pending·0 cites
- 2567US12416818B2Ophthalmic lenses for reducing myopic progression and methods of making the sameSIGHTGLASS VISION INC·Filed 2020·Granted Sep 16, 2025·0 cites·10 claims
- 2667US2025302922A1Methods and Compositions for Treating OsteoarthritisGENASCENCE CORP·Filed 2025·Application pending·0 cites
- 2767US2021338716A1Sodium Chlorite Compositions with Enhanced Anti-Viral and Anti-Microbial Efficacy and Reduced ToxicityIRENIX MEDICAL INC·Filed 2021·Application pending·0 cites
- 2866US2021388030A1Compositions and methods for intravitreal delivery of polynucleotides to retinal conesADVERUM BIOTECHNOLOGIES INC·Filed 2021·Application pending·0 cites
- 2964US12370240B2Methods and compositions for treating osteoarthritisGENASCENCE CORP·Filed 2019·Granted Jul 29, 2025·0 cites·20 claims
- 3064US11427931B2Mutant viral capsid libraries and related systems and methodsADVERUM BIOTECHNOLOGIES INC·Filed 2020·Granted Aug 30, 2022·0 cites·16 claims
- 3157US12270033B2Dual leucine zipper kinase inhibitors for gene therapyEXHAURA LTD·Filed 2020·Granted Apr 8, 2025·0 cites·16 claims
- 3257US2013323302A1Treatment of amd using aav sflt-1LIONS EYE INST LTD·Filed 2013·Application pending·0 cites
- 3357US2018311319A1Treatment of ocular neovascularization using anti-vegf proteinsAVALANCHE AUSTRALIA PTY LTD·Filed 2018·Application pending·0 cites
- 3456US2024264466A1Ophthalmic lenses for reducing myopia progression and laser-based methods for forming the sameSIGHTGLASS VISION INC·Filed 2022·Application pending·0 cites
- 3555US2009203067A1Photobioreactor Systems and Methods for Growing OrganismsECKERLE MATTHEW W·Filed 2008·Application pending·0 cites
- 3653US2009148928A1Heterotrophic ShiftHACKWORTH CHERYL A·Filed 2008·Application pending·0 cites
- 3749US2022011602A1Light scattering lens for treating myopia and eyeglasses containing the sameSIGHTGLASS VISION INC·Filed 2019·Application pending·0 cites
- 3847US2023181030A1Ophthalmic lenses, methods of manufacturing the ophthalmic lenses, and methods of dispensing eye care products including the sameSIGHTGLASS VISION INC·Filed 2021·Application pending·0 cites
- 3947US2023016631A1Methods for color-blindness remediation through image color correctionVISU INC·Filed 2020·Application pending·0 cites
- 4047US2021213203A1Active Agent Delivery Devices and Methods for Using the SameIRENIX MEDICAL INC·Filed 2019·Application pending·0 cites
- 4146US2022362402A1Compositions and methods for ocular therapyEXHAURA LTD·Filed 2020·Application pending·0 cites
- 4245US12092905B2Methods and devices for reducing myopia in childrenSIGHTGLASS VISION INC·Filed 2019·Granted Sep 17, 2024·0 cites·23 claims
- 4345US2021307963A1Active Agent Delivery Devices and Methods for Using the SameIRENIX MEDICAL INC·Filed 2019·Application pending·0 cites
- 4442US2019142975A1Evasion of neutralizing antibodies by a recombinant adeno-associated virusADVERUM BIOTECHNOLOGIES INC·Filed 2017·Application pending·0 cites
- 4541US2020143536A1Methods and systems for evaluating and reducing myopic potential of displayed color imagesUNIV WASHINGTON·Filed 2018·Application pending·0 cites
- 4640US2020206025A1Active Agent Delivery Devices and Methods for Using the SameIRENIX MEDICAL INC·Filed 2018·Application pending·0 cites
- 4740US2020390596A1Therapeutic Agent Delivery Devices Having Integrated Pain Mitigation, and Methods for Using the SameIRENIX MEDICAL INC·Filed 2019·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →